Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


23.10.2017

1 BMC Cancer
3 Br J Dermatol
2 Cancer
3 J Am Acad Dermatol
1 J Clin Invest
2 J Clin Oncol
1 Lancet Oncol
1 Nat Med
1 Oncogene
1 Oncol Rep
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. MIDDLETON MR, Atkins MB, Amos K, Wang PF, et al
    Societal preferences for adjuvant melanoma health states: UK and Australia.
    BMC Cancer. 2017;17:689.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. SCHAIDER H, Sturm RA
    The evolving universe of BRAF mutations in melanoma.
    Br J Dermatol. 2017;177:893.
    PubMed     Text format    

  3. ROBINSON JK, Spring B
    Personalized melanoma genomic risk information:perception of shared risk initiates sharing with family.
    Br J Dermatol. 2017;177:890-891.
    PubMed     Text format    

  4. SEO JW, Ha SM, Song KH
    Insulin-Like Growth Factor-II mRNA-Binding Protein 3 as a Novel Prognostic Biomarker for Acral Lentiginous Melanoma.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16077.
    PubMed     Text format     Abstract available


    Cancer

  5. AMIT M, Tam S, Abdelmeguid AS, Roberts DB, et al
    Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma.
    Cancer. 2017 Oct 17. doi: 10.1002/cncr.31083.
    PubMed     Text format     Abstract available

  6. MCWILLIAMS RR, Allred JB, Slostad JA, Katipamula R, et al
    NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab +/- everolimus for metastatic melanoma.
    Cancer. 2017 Oct 17. doi: 10.1002/cncr.31072.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  7. AYUBI E, Safiri S
    Histopathologic features of melanoma in difficult-to-diagnose lesions: A case-control study; methodological issues.
    J Am Acad Dermatol. 2017;77:e149.
    PubMed     Text format    

  8. FRAGA GR
    Reply to: "Histopathologic features of melanoma in difficult-to-diagnose lesions: A case-control study; methodological issues".
    J Am Acad Dermatol. 2017;77:e151.
    PubMed     Text format    

  9. CHANG TW, Weaver AL, Brewer JD, Kyle RA, et al
    Risk of Melanoma in Patients With Multiple Myeloma: A SEER Population-based Study.
    J Am Acad Dermatol. 2017 Oct 14. pii: S0190-9622(17)32540.
    PubMed     Text format    


    J Clin Invest

  10. ZHAN Y, Guo J, Yang W, Goncalves C, et al
    MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
    J Clin Invest. 2017 Oct 16. pii: 91258. doi: 10.1172/JCI91258.
    PubMed     Text format     Abstract available


    J Clin Oncol

  11. CARLINO MS, Sandhu S
    Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma.
    J Clin Oncol. 2017 Oct 19:JCO2017752055. doi: 10.1200/JCO.2017.75.2055.
    PubMed     Text format    

  12. CALLAHAN MK, Kluger H, Postow MA, Segal NH, et al
    Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study.
    J Clin Oncol. 2017 Oct 17:JCO2017722850. doi: 10.1200/JCO.2017.72.2850.
    PubMed     Text format     Abstract available


    Lancet Oncol

  13. GOURD E
    Oncolytic virus therapy in advanced melanoma.
    Lancet Oncol. 2017 Oct 12. pii: S1470-2045(17)30782.
    PubMed     Text format    


    Nat Med

  14. MURGAI M, Ju W, Eason M, Kline J, et al
    KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis.
    Nat Med. 2017;23:1176-1190.
    PubMed     Text format     Abstract available


    Oncogene

  15. CHEN XW, Yu TJ, Zhang J, Li Y, et al
    CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis.
    Oncogene. 2017;36:5045-5057.
    PubMed     Text format     Abstract available


    Oncol Rep

  16. CORDARO FG, De Presbiteris AL, Camerlingo R, Mozzillo N, et al
    Phenotype characterization of human melanoma cells resistant to dabrafenib.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5963.
    PubMed     Text format     Abstract available


    PLoS One

  17. NAKAMURA S, Kunikata T, Matsumoto Y, Hanaya T, et al
    Effects of a non-cyclodextrin cyclic carbohydrate on mouse melanoma cells: Characterization of a new type of hypopigmenting sugar.
    PLoS One. 2017;12:e0186640.
    PubMed     Text format     Abstract available

  18. MCWHIRTER SR, Duffy DL, Lee KJ, Wimberley G, et al
    Classifying dermoscopic patterns of naevi in a case-control study of melanoma.
    PLoS One. 2017;12:e0186647.
    PubMed     Text format     Abstract available

  19. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    PubMed     Text format     Abstract available

  20. CHEN LL, Zhu J, Schumacher J, Wei C, et al
    SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.
    PLoS One. 2017;12:e0184154.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: